UMED Clinical Trialssp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2023-10-17. Active
84 1050 1461 1000 0090 8256 8776- 17 1050 1461 1000 0090 8477 7896
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
If the management board is a one-person management board, one member of the management board is authorized to make declarations of will on behalf of the company. In the case of a multi-member management board, the President of the Management Board is authorized to make declarations of will independently on behalf of the company, whereas in all other cases joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required. In property matters whose value does not exceed PLN 50,000.00, each member of the management board may make declarations of will on behalf of the company independently.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Umed Sp. z o.o. | 99 | $26,742.30 | 99% |
Others | 1 | $270.12 | 1% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Bartłomiej Grobelski (45)  | Natural person holding a senior management position in a parent entity (e.g. parent company). | |
Radzisław Maciej Kordek (64) | Rektor uczelni wyższej będącej jedynym właścicielem spółki celowej umed |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| WP Radwansp. z o.o. | $2,306,366.78 | woodpartners.eu | ||
| Centrum Terapii Współczesnej J.M. JasnorzewskaS.K.A. | $1,145,077.18 | ctw.com.pl | ||
| Prodel R&Dsp. z o.o. | $941,906.54 | prodel.com.pl | ||
| Edurocosp. z o.o. | $126,644.58 | eduroco.pl | ||
| ConnectomeP.S.A. | $107,988.50 | connectome.name | ||
| Lightlogsp. z o.o. | $44,623.05 | lightlog.eu | ||
| Nevomo Pesp. z o.o. | $43,412.25 | nevomo.tech | ||
| TriomegaS.A. | $17,836.84 | triomega.pl | ||
| Ruxer-Poradniesp. z o.o. | — | ruxer-poradnie.pl | ||
| D Kosatkasp. z o.o. | — | dkosatka.com |
Change history
| Date | Event | |
|---|---|---|
| 2023-12-29 | Name change (Clinical Trials Umed → Umed Clinical Trials) | |
| 2023-07-28 | Entered in the register |
FAQ
Last updated: 2026-07-04